1. Home
  2. GRF vs INCR Comparison

GRF vs INCR Comparison

Compare GRF & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Capital Growth Fund Inc.

GRF

Eagle Capital Growth Fund Inc.

HOLD

Current Price

$9.97

Market Cap

39.9M

Sector

Finance

ML Signal

HOLD

Logo Intercure Ltd.

INCR

Intercure Ltd.

HOLD

Current Price

$1.09

Market Cap

47.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRF
INCR
Founded
1989
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.9M
47.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GRF
INCR
Price
$9.97
$1.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.8K
36.9K
Earning Date
01-01-0001
05-01-2026
Dividend Yield
3.70%
N/A
EPS Growth
N/A
N/A
EPS
1.16
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$69.54
Revenue Next Year
N/A
$41.75
P/E Ratio
$8.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.50
$0.68
52 Week High
$11.85
$1.77

Technical Indicators

Market Signals
Indicator
GRF
INCR
Relative Strength Index (RSI) 47.14 62.01
Support Level $9.96 $0.84
Resistance Level $10.13 $1.23
Average True Range (ATR) 0.09 0.06
MACD 0.01 -0.00
Stochastic Oscillator 29.33 74.20

Price Performance

Historical Comparison
GRF
INCR

About GRF Eagle Capital Growth Fund Inc.

Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock, giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: